Antares Pharma Overview
Company Headquarters: New Jersey, US
Founded: 1978
Workforce: 111
Company Working:
Antares Pharma is a combination of drug-device companies focused primarily on the development and commercialization of self-administered parenteral pharmaceutical products and technologies. The company develops, manufactures, and commercializes, novel therapeutic products using its advanced drug delivery systems that are designed to provide commercial or functional advantages, such as improved safety and efficacy, reduced side-effects, and enhanced patient comfort and adherence. Antares Pharma’s intramuscular and subcutaneous injection technology platforms include the Vibex and Vibex QuickShot pressure-assisted autoinjector systems suitable for branded and generic injectable drugs in unit dose containers as well as disposable multi-dose pen injectors. The company has a portfolio of proprietary and partnered commercial products and ongoing product development programs in various stages of development. It has formed significant strategic alliances and partnership arrangements with industry-leading pharmaceutical companies including Teva, Amag, and Pfizer.
Strategy
Antares Pharma focuses on acquiring new businesses and products which will strategically complement to its business model. The company identifies existing or newly approved drug formulations to apply its drug delivery technology to enhance its market share.
